80 related articles for article (PubMed ID: 8221670)
1. Systematic HRAS amplification in ovary-independent mammary tumors: correlation with progressively anaplastic phenotypes.
Aldaz CM; Gollahon LS; Chen A
Cancer Res; 1993 Nov; 53(22):5339-44. PubMed ID: 8221670
[TBL] [Abstract][Full Text] [Related]
2. Nonrandom abnormalities involving chromosome 1 and Harvey-ras-1 alleles in rat mammary tumor progression.
Aldaz CM; Chen A; Gollahon LS; Russo J; Zappler K
Cancer Res; 1992 Sep; 52(17):4791-8. PubMed ID: 1511443
[TBL] [Abstract][Full Text] [Related]
3. Genetic instability and the acquisition of metastatic ability by rat mammary cancer cells following v-H-ras oncogene transfection.
Ichikawa T; Kyprianou N; Isaacs JT
Cancer Res; 1990 Oct; 50(19):6349-57. PubMed ID: 2119253
[TBL] [Abstract][Full Text] [Related]
4. Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor.
Wang Y; Hu L; Yao R; Wang M; Crist KA; Grubbs CJ; Johanning GL; Lubet RA; You M
Oncogene; 2001 Nov; 20(53):7710-21. PubMed ID: 11753649
[TBL] [Abstract][Full Text] [Related]
5. Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis.
Haag JD; Hsu LC; Newton MA; Gould MN
Mol Carcinog; 1996 Nov; 17(3):134-43. PubMed ID: 8944073
[TBL] [Abstract][Full Text] [Related]
6. Alterations in the Ha-ras-1 and the p53 pathway genes in the progression of N-methyl-N-nitrosourea-induced rat mammary tumors.
McKenzie KE; Armstrong BA; Chen Y; Nagarajan M; Aldaz CM; Sukumar S
Mol Carcinog; 1997 Oct; 20(2):194-203. PubMed ID: 9364209
[TBL] [Abstract][Full Text] [Related]
7. Detection of differentially expressed genes in methylnitrosourea-induced rat mammary adenocarcinomas.
Hu L; Lin L; Crist KA; Kelloff GJ; Steele VE; Lubet RA; You M; Wang Y
J Cell Biochem Suppl; 1997; 28-29():117-24. PubMed ID: 9589356
[TBL] [Abstract][Full Text] [Related]
8. Amplification of Ki-ras and elevation of MAP kinase activity during mammary tumor progression in C3(1)/SV40 Tag transgenic mice.
Liu ML; Von Lintig FC; Liyanage M; Shibata MA; Jorcyk CL; Ried T; Boss GR; Green JE
Oncogene; 1998 Nov; 17(18):2403-11. PubMed ID: 9811472
[TBL] [Abstract][Full Text] [Related]
9. ras oncogene activation in mammary carcinomas induced by N-methyl-N-nitrosourea in Copenhagen rats.
Lu SJ; Archer MC
Mol Carcinog; 1992; 6(4):260-5. PubMed ID: 1485917
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic alterations in eight mammary tumors and tumor-suppressor gene p53 mutation in one mammary tumor from dogs.
Mayr B; Dressler A; Reifinger M; Feil C
Am J Vet Res; 1998 Jan; 59(1):69-78. PubMed ID: 9442248
[TBL] [Abstract][Full Text] [Related]
11. Frequent mutations of the Trp53, Hras1 and beta-catenin (Catnb) genes in 1,3-butadiene-induced mammary adenocarcinomas in B6C3F1 mice.
Zhuang SM; Wiseman RW; Söderkvist P
Oncogene; 2002 Aug; 21(36):5643-8. PubMed ID: 12165863
[TBL] [Abstract][Full Text] [Related]
12. Oncogene amplification in the proximal part of chromosome 6 in rat endometrial adenocarcinoma as revealed by combined BAC/PAC FISH, chromosome painting, zoo-FISH, and allelotyping.
Adamovic T; Trossö F; Roshani L; Andersson L; Petersen G; Rajaei S; Helou K; Levan G
Genes Chromosomes Cancer; 2005 Oct; 44(2):139-53. PubMed ID: 15942940
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-24 induces expression of beta4 integrin but suppresses anchorage-independent growth of rat mammary tumor cells by a mechanism that is independent of beta4.
Xuan W; Li YJ; Liu G; Ben-David Y; Archer MC
Mol Cancer Res; 2009 Mar; 7(3):433-42. PubMed ID: 19258414
[TBL] [Abstract][Full Text] [Related]
14. Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tag transgenic mice.
Liu ML; Shibata MA; Von Lintig FC; Wang W; Cassenaer S; Boss GR; Green JE
Oncogene; 2001 Apr; 20(16):2044-9. PubMed ID: 11360188
[TBL] [Abstract][Full Text] [Related]
15. Allelotypic and cytogenetic characterization of chemically induced mouse mammary tumors: high frequency of chromosome 4 loss of heterozygosity at advanced stages of progression.
Aldaz CM; Liao QY; Paladugu A; Rehm S; Wang H
Mol Carcinog; 1996 Nov; 17(3):126-33. PubMed ID: 8944072
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity at chromosome 1q loci in rat mammary tumors.
Gollahon LS; Chen A; Aldaz CM
Mol Carcinog; 1995 Jan; 12(1):7-13. PubMed ID: 7818765
[TBL] [Abstract][Full Text] [Related]
17. Midkine in the progression of rat N-nitroso-N-methylurea-induced mammary tumors.
Chen Y; McKenzie KE; Aldaz CM; Sukumar S
Mol Carcinog; 1996 Nov; 17(3):112-6. PubMed ID: 8944070
[TBL] [Abstract][Full Text] [Related]
18. Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray.
Skacel M; Ormsby AH; Pettay JD; Tsiftsakis EK; Liou LS; Klein EA; Levin HS; Zippe CD; Tubbs RR
Hum Pathol; 2001 Dec; 32(12):1392-7. PubMed ID: 11774175
[TBL] [Abstract][Full Text] [Related]
19. Absence of p53 mutations in methylnitrosourea-induced mammary tumors in rats.
Ogawa K; Tokusashi Y; Fukuda I
Cancer Detect Prev; 1996; 20(3):214-7. PubMed ID: 8769715
[TBL] [Abstract][Full Text] [Related]
20. Topoisomerase IIalpha gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study.
Kanta SY; Yamane T; Dobashi Y; Mitsui F; Kono K; Ooi A
Hum Pathol; 2006 Oct; 37(10):1333-43. PubMed ID: 16949920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
